Stevanato Group S.p.A. (NYSE:STVN) Position Raised by Thornburg Investment Management Inc.

Thornburg Investment Management Inc. grew its holdings in shares of Stevanato Group S.p.A. (NYSE:STVNFree Report) by 279.1% during the second quarter, Holdings Channel.com reports. The firm owned 746,218 shares of the company’s stock after buying an additional 549,378 shares during the quarter. Thornburg Investment Management Inc.’s holdings in Stevanato Group were worth $13,690,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of STVN. Hilltop National Bank increased its holdings in shares of Stevanato Group by 34.3% during the second quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock valued at $81,000 after purchasing an additional 1,122 shares during the period. PNC Financial Services Group Inc. increased its holdings in shares of Stevanato Group by 54.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 3,089 shares of the company’s stock valued at $84,000 after purchasing an additional 1,086 shares during the period. Harbor Capital Advisors Inc. increased its holdings in shares of Stevanato Group by 109.1% during the second quarter. Harbor Capital Advisors Inc. now owns 8,867 shares of the company’s stock valued at $163,000 after purchasing an additional 4,626 shares during the period. Raymond James Trust N.A. increased its holdings in shares of Stevanato Group by 18.7% during the second quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock valued at $188,000 after purchasing an additional 1,613 shares during the period. Finally, Oppenheimer Asset Management Inc. acquired a new position in shares of Stevanato Group during the first quarter valued at $241,000.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. Citigroup lowered their target price on Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Morgan Stanley lowered their target price on Stevanato Group from $26.00 to $22.00 and set an “equal weight” rating on the stock in a report on Monday, July 15th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of €30.60 ($33.63).

Check Out Our Latest Research Report on STVN

Stevanato Group Trading Up 0.4 %

NYSE:STVN opened at €20.20 ($22.20) on Thursday. The company has a quick ratio of 1.13, a current ratio of 1.74 and a debt-to-equity ratio of 0.19. Stevanato Group S.p.A. has a 1-year low of €16.56 ($18.20) and a 1-year high of €35.56 ($39.08). The firm has a market capitalization of $5.97 billion, a price-to-earnings ratio of 36.73, a price-to-earnings-growth ratio of 6.06 and a beta of 0.59. The stock has a fifty day simple moving average of €20.31 and a 200 day simple moving average of €23.37.

Stevanato Group (NYSE:STVNGet Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported €0.09 ($0.10) EPS for the quarter, missing analysts’ consensus estimates of €0.10 ($0.11) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 10.89% and a net margin of 11.27%. The business had revenue of €259.60 million for the quarter, compared to analyst estimates of €254.92 million. During the same quarter in the previous year, the business posted $0.15 earnings per share. The company’s revenue was up 1.7% compared to the same quarter last year. Sell-side analysts forecast that Stevanato Group S.p.A. will post 0.51 earnings per share for the current year.

Stevanato Group Profile

(Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Articles

Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVNFree Report).

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.